Variant report

Variant	esv3395132
Chromosome Location	chr5:180044796-180047594
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:250)
CpG islands
(count:489)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:250 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CREB1	chr5:180045842-180046437	A549	lung:	n/a	n/a
2	CTCF	chr5:180046020-180046170	RPTEC	kidney:	n/a	n/a
3	CTCF	chr5:180046240-180046390	GM12871	blood:	n/a	n/a
4	CTCF	chr5:180046260-180046410	SK-N-SH_RA	brain:	n/a	n/a
5	CTCF	chr5:180045806-180046564	H1-hESC	embryonic stem cell:	n/a	n/a
6	CTCF	chr5:180046260-180046410	GM12866	blood:	n/a	n/a
7	CTCF	chr5:180046180-180046330	HVMF	connective:	n/a	n/a
8	CTCF	chr5:180046300-180046450	HEK293	kidney:	n/a	n/a
9	CTCF	chr5:180046204-180046539	HepG2	liver:	n/a	n/a
10	CTCF	chr5:180046560-180046710	AG09309	skin:	n/a	n/a
11	CTCF	chr5:180046580-180046730	WI-38	lung:	n/a	n/a
12	CTCF	chr5:180046266-180046410	GM13976	blood:	n/a	n/a
13	CTCF	chr5:180046580-180046730	AG04450	lung:	n/a	n/a
14	CTCF	chr5:180045980-180046130	NHEK	skin:	n/a	n/a
15	CTCF	chr5:180045980-180046130	HMF	breast:	n/a	n/a
16	CTCF	chr5:180046288-180046429	Pancreas_OC	pancreas:	n/a	n/a
17	CTCF	chr5:180046320-180046470	HAc	cerebellar:	n/a	n/a
18	CTCF	chr5:180046000-180046150	HPF	lung:	n/a	n/a
19	CTCF	chr5:180046260-180046410	HFF-Myc	foreskin:	n/a	n/a
20	CTCF	chr5:180045980-180046130	HCFaa	heart:	n/a	n/a
21	CTCF	chr5:180046000-180046150	HCPEpiC	choroid plexus:	n/a	n/a
22	CTCF	chr5:180046260-180046410	HEK293	kidney:	n/a	n/a
23	CTCF	chr5:180046240-180046390	WERI-Rb-1	eye:	n/a	n/a
24	CTCF	chr5:180046240-180046390	RPTEC	kidney:	n/a	n/a
25	CTCF	chr5:180046077-180046094	GM19239	blood:	n/a	n/a
26	CTCF	chr5:180046300-180046450	HRPEpiC	eye:	n/a	n/a
27	CTCF	chr5:180046060-180046210	NHEK	skin:	n/a	n/a
28	CTCF	chr5:180046060-180046210	GM12870	blood:	n/a	n/a
29	CTCF	chr5:180046062-180046107	GM19240	blood:	n/a	n/a
30	CTCF	chr5:180046240-180046390	HPAF	blood vessel:	n/a	n/a
31	CTCF	chr5:180046220-180046479	NHEK	skin:	n/a	n/a
32	CTCF	chr5:180045971-180046212	LNCaP	prostate:	n/a	n/a
33	CTCF	chr5:180046020-180046170	HVMF	connective:	n/a	n/a
34	CTCF	chr5:180046000-180046150	HEK293	kidney:	n/a	n/a
35	CTCF	chr5:180045964-180046152	A549	lung:	n/a	n/a
36	CTCF	chr5:180045978-180046182	Medullo	brain:	n/a	n/a
37	CTCF	chr5:180046000-180046150	AoAF	blood vessel:	n/a	n/a
38	CTCF	chr5:180046029-180046169	Pancreas_OC	pancreas:	n/a	n/a
39	CTCF	chr5:180046240-180046390	GM12873	blood:	n/a	n/a
40	CTCF	chr5:180046260-180046410	AG10803	skin:	n/a	n/a
41	CTCF	chr5:180045969-180046425	ECC-1	luminal epithelium:	n/a	n/a
42	CTCF	chr5:180046220-180046370	HUVEC	blood vessel:	n/a	n/a
43	CTCF	chr5:180046300-180046450	HCPEpiC	choroid plexus:	n/a	n/a
44	CTCF	chr5:180046168-180046428	A549	lung:	n/a	n/a
45	CTCF	chr5:180045980-180046130	HBMEC	blood vessel:	n/a	n/a
46	CTCF	chr5:180045978-180046511	GM12891	blood:	n/a	n/a
47	CTCF	chr5:180046205-180046507	Medullo	brain:	n/a	n/a
48	CTCF	chr5:180046034-180046152	GM19238	blood:	n/a	n/a
49	CTCF	chr5:180045729-180046730	A549	lung:	n/a	n/a
50	CTCF	chr5:180045919-180046443	A549	lung:	n/a	n/a

(count:489 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:180045822-180045872	AG09309	skin:	n/a
2	chr5:180045822-180045872	AG09309	skin:	n/a
3	chr5:180045822-180045872	GM19239	blood:	n/a
4	chr5:180047299-180047349	HCPEpiC	choroid plexus:	n/a
5	chr5:180045822-180045872	HUVEC	blood vessel:	n/a
6	chr5:180046528-180046578	PFSK-1	brain:	n/a
7	chr5:180045822-180045872	BJ	skin:	n/a
8	chr5:180045597-180045647	ProgFib	skin:	n/a
9	chr5:180046052-180046102	AG09309	skin:	n/a
10	chr5:180046901-180046951	Hepatocyte	liver:	n/a
11	chr5:180047407-180047457	AG04450	lung:	fetal
12	chr5:180045822-180045872	HPAEpiC	pulmonary alveolar:	n/a
13	chr5:180046528-180046578	NH-A	brain:	n/a
14	chr5:180045822-180045872	U87	brain:	n/a
15	chr5:180047299-180047349	ECC-1	luminal epithelium:	n/a
16	chr5:180046052-180046102	HepG2	liver:	n/a
17	chr5:180045597-180045647	HAEpiC	amniotic membrane:	n/a
18	chr5:180047299-180047349	NB4	blood:	n/a
19	chr5:180046528-180046578	HCF	heart:	n/a
20	chr5:180046901-180046951	A549	lung:	n/a
21	chr5:180046528-180046578	HNPCEpiC	eye:	n/a
22	chr5:180046052-180046102	GM12891	blood:	n/a
23	chr5:180047299-180047349	A549	lung:	n/a
24	chr5:180046052-180046102	NHDF-neo	bronchial:	n/a
25	chr5:180045822-180045872	GM12878	blood:	n/a
26	chr5:180046052-180046102	PrEC	prostate:	n/a
27	chr5:180046901-180046951	AoSMC	blood vessel:	n/a
28	chr5:180047407-180047457	CMK	blood:	n/a
29	chr5:180047299-180047349	MCF10A-Er-Src	breast:	n/a
30	chr5:180047299-180047349	HNPCEpiC	eye:	n/a
31	chr5:180046052-180046102	U87	brain:	n/a
32	chr5:180047299-180047349	PrEC	prostate:	n/a
33	chr5:180047407-180047457	K562	blood:	n/a
34	chr5:180046052-180046102	PANC-1	pancreas:	n/a
35	chr5:180046901-180046951	Hela-S3	cervix:	n/a
36	chr5:180047299-180047349	RPTEC	kidney:	n/a
37	chr5:180045597-180045647	IMR90	lung:	fetal
38	chr5:180047299-180047349	ProgFib	skin:	n/a
39	chr5:180045822-180045872	NH-A	brain:	n/a
40	chr5:180045597-180045647	HNPCEpiC	eye:	n/a
41	chr5:180047184-180047234	GM06990	blood:	n/a
42	chr5:180046528-180046578	ECC-1	luminal epithelium:	n/a
43	chr5:180046901-180046951	BE2_C	brain:	n/a
44	chr5:180046528-180046578	SK-N-MC	brain:	n/a
45	chr5:180046052-180046102	HRPEpiC	eye:	n/a
46	chr5:180046528-180046578	ProgFib	skin:	n/a
47	chr5:180047184-180047234	HAEpiC	amniotic membrane:	n/a
48	chr5:180047407-180047457	HCPEpiC	choroid plexus:	n/a
49	chr5:180045822-180045872	NHBE	bronchial:	n/a
50	chr5:180047184-180047234	Hela-S3	cervix:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr5:180031301..180033388-chr5:180043244..180045976,2	MCF-7	breast:
2	chr5:179758608..179760983-chr5:180044449..180046070,2	MCF-7	breast:

No data

Variant related genes	Relation type
FLT4	TF binding region
FLT4	CpG island
ENSG00000131459	chromatin interactions

Extended variants
information (count: 193 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:193 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs113840370	chr5:180044797-180044798	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs113680326	chr5:180044818-180044819	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs36076362	chr5:180044829-180044830	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs113073607	chr5:180044853-180044854	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs442186	chr5:180044870-180044871	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs550643693	chr5:180044876-180044877	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs188414723	chr5:180044888-180044889	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs452042	chr5:180044891-180044892	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs112285458	chr5:180044919-180044920	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs536427417	chr5:180044925-180044926	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs111611458	chr5:180044954-180044955	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs112342735	chr5:180044962-180044963	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs113041978	chr5:180044981-180044982	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs421358	chr5:180044985-180044986	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs546591574	chr5:180045017-180045018	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs111479997	chr5:180045042-180045043	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs112932966	chr5:180045049-180045050	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs113491683	chr5:180045055-180045056	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs372907235	chr5:180045070-180045071	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs202124106	chr5:180045080-180045081	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs112024488	chr5:180045113-180045114	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs112206046	chr5:180045128-180045129	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs55710414	chr5:180045132-180045133	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs13171825	chr5:180045156-180045157	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs199548068	chr5:180045163-180045164	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs13157580	chr5:180045178-180045179	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs111739737	chr5:180045193-180045194	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs376945662	chr5:180045197-180045198	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs380341	chr5:180045209-180045210	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs13170798	chr5:180045222-180045223	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs370166202	chr5:180045230-180045231	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs566729967	chr5:180045269-180045270	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs539035547	chr5:180045272-180045273	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs559038359	chr5:180045322-180045323	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs200361218	chr5:180045329-180045330	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs376438760	chr5:180045331-180045332	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs36003320	chr5:180045333-180045334	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs13153861	chr5:180045374-180045375	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs192060710	chr5:180045376-180045377	Weak transcription Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs575699997	chr5:180045400-180045401	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS Genic enhancers Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs449774	chr5:180045401-180045402	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Genic enhancers Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs370533006	chr5:180045423-180045424	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Genic enhancers Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs56112665	chr5:180045424-180045425	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Genic enhancers Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs55727245	chr5:180045438-180045439	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Genic enhancers Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs148241522	chr5:180045453-180045454	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Genic enhancers Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs574955808	chr5:180045461-180045462	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Genic enhancers Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs184155798	chr5:180045473-180045474	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Genic enhancers Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs116531825	chr5:180045491-180045492	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Genic enhancers Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs561535570	chr5:180045512-180045513	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Genic enhancers Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs140517010	chr5:180045518-180045519	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Genic enhancers Enhancers Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Thyroid cancer	19087340	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sotos syndrome	21572526	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Sotos syndrome	17561922	CNVD
Sotos syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Sotos syndrome	22470819	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Acute myeloid leukemia	18000384	CNVD
Sudden cardiac death	19188705	CNVD
Basal cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Lung cancer	17297452	CNVD
Cancer	20164920	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Sotos syndrome	22283845	CNVD
Breast cancer	16272173	CNVD
Sotos syndrome	20503325	CNVD
Lung adenocarcinoma	17086460	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	19181860	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Ehlers-danlos syndrome	17576883	CNVD
Lung cancer	17086460	CNVD
Autism	19246517	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Autism	22543975	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Schizophrenia	23813976	CNVD
Schizophrenia	21346763	CNVD

Chromatin state (count:220 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:180018800-180045800	Weak transcription	Right Atrium	heart
2	chr5:180029400-180045600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
3	chr5:180040000-180061200	Weak transcription	Gastric	stomach
4	chr5:180041400-180044800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
5	chr5:180042200-180045400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
6	chr5:180042200-180045400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
7	chr5:180043000-180045800	Weak transcription	Liver	Liver
8	chr5:180044000-180044800	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
9	chr5:180044000-180045400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
10	chr5:180044000-180045400	Weak transcription	Spleen	Spleen
11	chr5:180044000-180046000	Weak transcription	Lung	lung
12	chr5:180044800-180045400	Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
13	chr5:180044800-180046600	Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr5:180045400-180045600	Flanking Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
15	chr5:180045400-180045600	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr5:180045400-180045600	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
17	chr5:180045400-180045600	Active TSS	Primary hematopoietic stem cells short term culture	blood
18	chr5:180045400-180045600	Enhancers	Primary T helper cells fromperipheralblood	blood
19	chr5:180045400-180045600	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
20	chr5:180045400-180045600	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin01	Skin
21	chr5:180045400-180045600	Bivalent Enhancer	Brain Germinal Matrix	brain
22	chr5:180045400-180045600	Enhancers	Esophagus	oesophagus
23	chr5:180045400-180045600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
24	chr5:180045400-180045600	Bivalent Enhancer	Fetal Muscle Leg	muscle
25	chr5:180045400-180045600	Bivalent Enhancer	Placenta	Placenta
26	chr5:180045400-180045600	Bivalent Enhancer	Right Ventricle	heart
27	chr5:180045400-180045800	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
28	chr5:180045400-180045800	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
29	chr5:180045400-180045800	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
30	chr5:180045400-180045800	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
31	chr5:180045400-180045800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
32	chr5:180045400-180045800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
33	chr5:180045400-180046000	Bivalent/Poised TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
34	chr5:180045400-180046200	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
35	chr5:180045400-180046400	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
36	chr5:180045400-180046400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
37	chr5:180045400-180046400	Bivalent/Poised TSS	Brain Inferior Temporal Lobe	brain
38	chr5:180045400-180046400	Bivalent/Poised TSS	Fetal Stomach	stomach
39	chr5:180045400-180046400	Bivalent/Poised TSS	NHEK	skin
40	chr5:180045400-180046600	Active TSS	H9 Cell Line	embryonic stem cell
41	chr5:180045400-180046600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
42	chr5:180045400-180046600	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
43	chr5:180045400-180046600	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
44	chr5:180045400-180046800	Active TSS	A549	lung
45	chr5:180045400-180047000	Genic enhancers	Spleen	Spleen
46	chr5:180045600-180045800	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
47	chr5:180045600-180045800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
48	chr5:180045600-180045800	Flanking Bivalent TSS/Enh	Ganglion Eminence derived primary cultured neurospheres	brain
49	chr5:180045600-180045800	Bivalent/Poised TSS	Foreskin Melanocyte Primary Cells skin01	Skin
50	chr5:180045600-180045800	Flanking Active TSS	Brain Angular Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links